Search

Ragweed pollen extract

The company has initiated a phase III trial with its product for oral immunotherapy of ragweed allergy.

Betrixaban

for VTE [A27285]. … Betrixaban, now developed by Portola Pharmaceuticals Inc., is prescribed as a venous thromboembolism (VTE) prophylactic for adult patients with moderate to severe restricted motility or with other risks

Molybdenum

Molybdenum is a chemical element with symbol Mo and atomic number 42. As it is not a naturally occuring free metal on Earth, molybdenum is found only in various oxidation states in minerals. Molybdenum is commonly used in metallurgy and ...

Racemethionine

A preparation of methionine that includes a mixture of D-methionine and L-methionine isomers.

Sodium phosphate, dibasic, unspecified form

Omaveloxolone

[L45424] The EMA approved this drug the following year, in February 2024, and Health Canada in March 2025 for the same condition. … [A257529] In February 2023, omaveloxolone was approved by the FDA for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older.

Lactose

It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.

Alteplase

However, its use for the treatment of acute ischemic stroke (AIS) has increased over the years. … [A252345,L43125] It was first approved by the FDA in 1987 for the management of thromboembolic disease, including acute myocardial infarction (AMI).

1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))

The product was meant to compensate for alveolar surfactant deficiency and reduce to likelihood of alveolar collapse leading to acute respiratory collapse.

Haemophilus influenzae b polysaccharide-tetanus conjugate